Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2022 Dec;28(12):2580–2582. doi: 10.3201/eid2812.221118

Delayed Diagnosis of Acute Q Fever, China

Dan Li 1,2,3, Hui Liu 1,2,3,, Ming Liu 1,2,3, Caiyun Chang 1,2,3, Xiaodong Zhao 1,2,3, Hao Yu 1,2,3, Lina Yan 1,2,3, Huiju Han 1,2,3, Xue-jie Yu 1,2,3,
PMCID: PMC9707575  PMID: 36418013

Abstract

We report a patient in China with fever of unknown origin who visited 3 hospitals in 3 weeks and was finally given a diagnosis of acute Q fever, determined by metagenomics next-generation sequencing. Our results indicate that physicians are unfamiliar with Q fever and the disease is neglected in China.

Keywords: acute Q fever, China, zoonoses, Coxiella burnetii, bacteria


Q fever is an important worldwide zoonosis with nonspecific symptoms, making diagnosis challenging (13). Humans become infected mainly by inhalation of Coxiella burnetii–contaminated aerosols from animal waste or contaminated soil (4). C. burnetii is listed as a biologic weapon in the United States, and Q fever is a nationally notifiable disease in the United States, Australia, Netherlands, and Japan, but it is not a notifiable disease in China (2,57). Serologic epidemiology indicates that C. burnetii is widely distributed in China, but Q fever is rarely reported and might be neglected (2,7). We report a case of Q fever in a man in Shandong Province, China. The need for ethics approval and informed consent was waived, granted by the National Health Commission of China as part of outbreak investigation of infectious disease.

A 55-year-old man in a rural area of Jinan, Shandong Province, China, had fever (38.3 °C), headache, fatigue, loss of appetite, and myalgia develop on August 24, 2019 (Figure 1). He visited a local town hospital and was treated with acetaminophen and chlorpheniramine. When his symptoms persisted, he visited a county hospital on the 9th day after illness onset with a body temperature of 38.5°C and was treated with oral cefprozil and levofloxacin. On the 14th day of illness, with no improvement of his symptoms, he was transferred to a local municipal hospital. At admission, his body temperature was 39.0°C. Blood tests revealed elevation in neutrophil count and ratio, C-reactive protein, serum procalcitonin, and liver enzymes (Table). Bacterial culture showed no growth of microorganisms in either aerobic or anaerobic cultures (BD BACTEC FX 200 blood culture instrument, https://www.bd.com). We used PCR or immunologic test kits to test for viruses (influenza virus, severe fever with thrombocytopenia syndrome virus, Hantan virus, hepatitis B, hepatitis C, Epstein-Barr, and cytomegalovirus) and bacteria (Brucella, Mycobacterium tuberculosis, typhoid, and paratyphoid). We observed no positive results.

Figure 1.

Figure 1

Timeline of illness in a patient with Q fever in Shandong Province, China, 2019. mNGS, metagenomics next-generation sequencing.

Table. Blood and biochemical indicators for a patient with Q fever, Shandong Province, China, 2019.

Category Value Reference range
Neutrophil count, × 109 cells/L 8.30 2.00–7.00
Neutrophils, % 86.20 50.00–70.00
Leukocyte, × 109 cells/L 9.64 4–10
Leukomonocyte, × 109 cells/L 0.79 0.80–4.0
Platelet, × 109/L 210 100–300
Erythrocytes, × 1012 cells/L 4.13 4.0–5.5
C-reactive protein, mg/L 21.96 0.068–8.20
Serum procalcitonin, ng/mL 2.50 0–0.05
Alanine aminotransferase, U/L 99 0–40
Alkaline phosphatase, U/L 208 40–150
Aspartate transaminase, U/L 51 0–40
Gamma-glutamyl transpeptidase, U/L 333 12–64

We sent samples to the CapitalBio MedLab in Beijing, China, where metagenomics next-generation sequencing (mNGS) was performed to determine the etiologic agent (Ion Proton Sequencer, https://www.thermofisher.com). A blood sample obtained from the patient provided DNA for that analysis (QIAamp MinElute ccfDNA Mini Kit; https://www.qiagen.com). On the 19th day after illness onset, the mNGS result revealed C. burnetii sequences in the patient’s blood sample; no other pathogens were observed. The sequence coverage rate of the C. burnetii genome was 97.66% (2,078,829 bp) with 137,272 reads (average length 141 bp, average quality 23), 1,105 contigs (range 262–16,242 bp), and an estimated 1.80 × 104 copies/mL of C. burnetii in the sequencing sample. The mNGS result clearly indicated that the patient was infected with C. burnetii. Phylogenetic analysis revealed that the isocitrate dehydrogenase sequence from the patient formed a monophyletic group with sequences of C. burnetii from goats and from humans diagnosed with acute Q fever from GenBank (Figure 2). The isocitrate dehydrogenase sequence homology between the patient and those sequences were 99.85%–99.92%.

Figure 2.

Figure 2

Phylogenetic tree of Coxiella burnetii from a patient with Q fever in Shandong Province, China, 2019. Triangle indicates the strain detected in this study. The phylogenetic tree was constructed using the complete isocitrate dehydrogenase gene sequence (1,300-bp) with the maximum-likelihood method using MEGA 7.0 (https://www.megasoftware.net). Bootstrap values >50% from 1,000 replicates (shown on the nodes). Scale bar indicates substitutions per site.

We performed cardiac ultrasound of the patient, which showed normal cardiopulmonary function and ruled out Q fever endocarditis. We treated the patient with oral doxycycline (100 mg 2×/d). His symptoms disappeared in 1 week, and he was discharged and continued on oral doxycycline (100 mg 2×/d) for 1 more week. We followed the patient for 1 year, noting no recurrence of Q fever.

This patient worked as a woodworker in a village without nearby abattoirs. He did not raise animals, but there were goats in his village, and mice were often observed around his living and working places. He denied any contact with domesticated or wild animals, ingestion of unpasteurized dairy products or uncooked meat, tick bite, exposure to similar patients, or any travel history to other places in China or abroad in the months before his illness.

Multiple factors likely delayed diagnosis of this patient with Q fever. Although nonspecific symptoms contributed, the greatest obstacles to diagnosis, we believe, were unawareness of the existence of Q fever by physicians and lack of conventional diagnostic reagents of Q fever, such as serologic and C. burnetii–specific PCR reagents, in the medical institutions our patient visited (8,9).

In conclusion, we report a patient with febrile illness from Shandong Province, China, without etiologic diagnosis and appropriate treatment for 3 weeks, until mNGS revealed C. burnetii genomic sequences in the patient’s blood. Our study suggests that physicians need to be more aware that Q fever is widespread in China and should be considered when diagnosing patients with persistent fever of unknown origin, even without clear exposure history. In addition, conventional diagnostic reagents of Q fever should be stored in local medical institutions in China. mNGS is a method to randomly sequence all nucleic acids and identify organisms by bioinformatics analysis in a sample, which is useful in identifying unknown pathogens. Our case supports previous studies that demonstrated that mNGS can be used to diagnose Q fever and other pathogens in humans (10).

Acknowledgments

Contigs of C. burnetii from this patient are available upon request from the authors.

Acknowledgments

We thank the local health sector for blood samples and field support.

This study was supported by a grant from the National Natural Science Funds of China (grant no. 81971939).

Biography

Dan Li is a PhD candidate at the School of Public Health, Wuhan University, Wuhan, Hubei, China. Her research interest is epidemiology of emerging infectious diseases.

Footnotes

Suggested citation for this article: Li D, Liu H, Liu M, Chang C, Zhao X, Yu H, et al. Delayed diagnosis of acute Q fever, China. Emerg Infect Dis. 2022 Dec [date cited]. https://doi.org/10.3201/eid2812.221118

References

  • 1.Derrick EH. “Q” fever, a new fever entity: clinical features, diagnosis and laboratory investigation. Rev Infect Dis. 1983;5:790–800. 10.1093/clinids/5.4.790 [DOI] [PubMed] [Google Scholar]
  • 2.El-Mahallawy HS, Lu G, Kelly P, Xu D, Li Y, Fan W, et al. Q fever in China: a systematic review, 1989-2013. Epidemiol Infect. 2015;143:673–81. 10.1017/S0950268814002593 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Karageorgou I, Kogerakis N, Labropoulou S, Hatzianastasiou S, Mentis A, Stavridis G, et al. Q fever endocarditis and a new genotype of Coxiella burnetii, Greece. Emerg Infect Dis. 2020;26:2527–9. 10.3201/eid2610.191616 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Parker NR, Barralet JH, Bell AM. Q fever. Lancet. 2006;367:679–88. 10.1016/S0140-6736(06)68266-4 [DOI] [PubMed] [Google Scholar]
  • 5.Madariaga MG, Rezai K, Trenholme GM, Weinstein RA. Q fever: a biological weapon in your backyard. Lancet Infect Dis. 2003;3:709–21. 10.1016/S1473-3099(03)00804-1 [DOI] [PubMed] [Google Scholar]
  • 6.Devaux CA, Osman IO, Million M, Raoult D. Coxiella burnetii in dromedary camels (Camelus dromedarius): a possible threat for humans and livestock in North Africa and the Near and Middle East? Front Vet Sci. 2020;7:558481. 10.3389/fvets.2020.558481 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Huang M, Ma J, Jiao J, Li C, Chen L, Zhu Z, et al. The epidemic of Q fever in 2018 to 2019 in Zhuhai city of China determined by metagenomic next-generation sequencing. PLoS Negl Trop Dis. 2021;15:e0009520. 10.1371/journal.pntd.0009520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Stein A, Raoult D. Detection of Coxiella burnetti by DNA amplification using polymerase chain reaction. J Clin Microbiol. 1992;30:2462–6. 10.1128/jcm.30.9.2462-2466.1992 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Anderson A, Bijlmer H, Fournier PE, Graves S, Hartzell J, Kersh GJ, et al. Diagnosis and management of Q fever—United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep. 2013;62(RR-03):1–30. [PubMed] [Google Scholar]
  • 10.Simner PJ, Miller S, Carroll KC. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis. 2018;66:778–88. 10.1093/cid/cix881 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES